Inphi Corporation Announces Proposed Offering of $150.0

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Inphi Corporation Announces Proposed Offering of $150.0 Million of Convertible Senior Notes

SANTA CLARA, CA--(Marketwired - Dec 1, 2015) - Inphi Corporation (NYSE: IPHI) today announced its intention to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of convertible senior notes due 2020 (the "notes") in a private offering to qualified institutional buyers pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). In connection with the offering, Inphi expects to grant the initial purchasers of the notes an option to purchase up to an additional $22.5 million aggregate principal amount of notes on the same terms and conditions.

Inphi intends to use a portion of the net proceeds from the offering of the notes to pay the cost of certain capped call transactions (described below). Inphi intends to use the remainder of the net proceeds from the offering of the notes for general corporate purposes, including financing potential acquisitions and other strategic transactions. However, Inphi currently has no commitments with respect to any such acquisitions or other strategic transactions.

When issued, the notes will be unsecured, senior obligations of Inphi, and interest will be payable semi-annually. Prior to June 1, 2020, the notes will become convertible only under certain circumstances and during certain periods. Inphi will settle conversions of the notes by paying or delivering, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at its election. Final terms of the notes, including the interest rate, the initial conversion rate and other terms, will be determined at the time of pricing by negotiations between Inphi and the initial purchasers of the notes. 

If the initial purchasers exercise their option to purchase additional notes, Inphi intends to use the resulting additional proceeds of the sale of the additional notes to pay the cost of entering into additional capped call transactions and for general corporate purposes, including financing potential acquisitions and other strategic transactions.

In connection with the pricing of the notes, Inphi expects to enter into privately negotiated capped call transactions with one or more financial institutions, which may include one or more of the initial purchasers or their respective affiliates (the "option counterparties"). The capped call transactions are expected generally to reduce the potential dilution to Inphi's common stock upon any conversion of the notes and/or offset the potential cash payments Inphi is required to make in excess of the principal amount upon conversion of the notes in the event that the market price of Inphi's common stock is greater than the strike price of the capped call transactions.

Inphi expects that in connection with establishing their initial hedge of the capped call transactions, the option counterparties or their respective affiliates will enter into various derivative transactions with respect to Inphi's common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Inphi's common stock or the notes at that time, and could result in a higher effective conversion price for the notes.

In addition, Inphi has been advised by the option counterparties that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivative transactions with respect to Inphi's common stock and/or purchasing or selling Inphi's common stock in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period related to a conversion of the notes). This activity could also cause or avoid an increase or a decrease in the market price of Inphi's common stock or the notes, which could affect the ability of noteholders to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of the notes, it could affect the amount and value of the consideration that noteholders will receive upon conversion of the notes.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful. The notes and the shares of Inphi's common stock issuable upon conversion of the notes, if any, have not been registered under the Securities Act or the securities laws of any other jurisdiction and, unless so registered, may not be offered or sold in the United States except pursuant to an exemption from such registration requirements.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intention to offer the notes, the intended use of net proceeds from the offering and the expected terms of the offering. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including risks related to whether Inphi will offer the notes or consummate the offering of the notes on the expected terms, or at all, the potential impact of market and other general economic conditions, whether Inphi will be able to satisfy the conditions required to close any sale of the notes, the anticipated use of the net proceeds of the offering, the fact that Inphi's management will have broad discretion in the use of the proceeds from any sale of the notes, whether the capped call transactions will become effective, and other risks detailed from time to time in Inphi's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2015. The forward-looking statements in this press release are based on information available to Inphi as of the date hereof, and Inphi does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Corporate Contact: Kim Markle Inphi 408-217-7329 kmarkle@inphi.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Limber Health's New Tool Set to Revolutionize Rehab

Updated Category News Views 2

A Shift in Rehab Therapy Alright, it's not every day you see a seismic shift in the world of rehab therapy. Limber Health just dropped the mic with their brand-new Recovery Forecast. Built on the heftiest risk-adjusted patient outcomes database in the game, this tool aims to replace those old-school, single-snapshot forecasts with a full 90-day predictive outlook. If you...

Continue Reading
Top Gun F/A-18 Super Hornet Lands at Palm Springs

Updated Category News Views 9

Aviation Marvel Now Anchored at Palm Springs There's something electric about standing next to a piece of history, especially when it involves the thunderous scream of an F/A-18 Super Hornet. The Palm Springs Air Museum is pulling back the curtains on an experience that's got aviation buffs and Top Gun fans buzzing like bees. On November 7, 2026, this central hub of...

Continue Reading
Millrose Faces Class Action: Blame Game in Motion

Updated Category News Views 0

Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...

Continue Reading
Alternative Data Market Set to Boom, Hits $40B by 2035

Updated Category News Views 0

Eyeing the Big Leap in Alternative Data Folks, this alternative data market's growth isn’t just another blip on the radar. We’re staring down a transformation—credence's figures forecast this space reaching a staggering $40.35 billion by 2035. It’s like watching a penny stock turning blue-chip overnight. For reference, that’s a 20.37% annual growth swing from a...

Continue Reading
3D Concrete Printing Set to Transform Construction by 2035

Updated Category News Views 0

Concrete Revolution: The 3D Printing Surge Times are changing in construction, and this ain’t your grandfather’s cinder block. We're talking about 3D concrete printing here—an industry poised to swell from just a pipedream sort of $293.4 million in 2025 to a staggering $1.87 billion by 2035. Driven by housing demands and resilient defense contracts, the sector is...

Continue Reading
AMTD IDEA Group: Expanding Its Global Reach

Updated Category News Views 7

AMTD IDEA's Expansive Global Footprint While the rest of the market whirls, AMTD IDEA Group (NYSE: AMTD) is steadying itself with a comprehensive expansion that, quite frankly, demands a second look. Between weaving global media threads and dipping their toes into every alluring venture space, they've formed a tapestry not many could replicate. With facilities stretching...

Continue Reading
DaVita's Stand on HHS Kidney Plan: Innovation at Core

Updated Category News Views 8

DaVita Stands Firm on Kidney Care Innovation The healthcare landscape's shifting undercurrent, folks, and kidney care has landed smack in the spotlight with the U.S. Department of Health and Human Services (HHS) putting forth its Kidney Care National Plan. Now, this isn't some bureaucratic mumbo-jumbo—this plan's setting the tone for kidney disease treatment across...

Continue Reading
Plaid Eyes Data Horizons; Acorns Embraces Gen Z

Updated Category News Views 5

Fintech's Next Frontier: Plaid's Vision You ever get the feeling some folks see further down the road than others? That's Plaid CTO Will Robinson, chatting up the NYSE folks at Money20/20. The man’s got his eyes on what he calls "making sense" of financial data—no small feat in our swamped digital world. Plaid ain't some penny stock operation, either. This is an $8...

Continue Reading
EverSmith Rolls Out Training Hub to Propel Franchise Growth

Updated Category News Views 4

Big Ambitions Nestled in Milford, Ohio Beneath the glow of fluorescent lights in a fresh-to-the-world 12,000-square-foot box of opportunity, EverSmith Brands is betting on big returns. EverHUB has opened its doors, aiming to be the cradle that hatches their aggressive franchise dreams into reality. It's not just brick and mortar—it’s the manifestation of their grand...

Continue Reading
American Lung Association Tackles Indoor Pollution

Updated Category News Views 1

The Unseen Threat Lurking Indoors When you think about air pollution, your mind probably jumps to smog-choked city streets. But, surprise! The air inside your cozy living room could actually be pulling a fast one on you, being two to five times filthier than what’s outside. Now, that’s a hair-raising thought. A Closer Look at Indoor Air Hazards Folks don’t usually...

Continue Reading

Top 5 Most Recently Viewed Articles

Kinetics Begins Building High-Capacity FSRU for LNG

Updated Category News Views 15

Big Plans on the High Seas Here's another twist in the endless ocean of energy infrastructure milestones—Kinetics, the brainchild of Karpowership, is breaking ground, or rather, cutting steel in Singapore for its first high-capacity Floating Storage and Regasification Unit (FSRU). Just another day in the volatile world of LNG, right? This latest venture, tagged as LNGT...

Continue Reading
Revance Therapeutics: Investigating Possible Securities Fraud

Updated Category News Views 157

Revance Therapeutics Faces Legal Scrutiny It has come to light that Revance Therapeutics, Inc. (NASDAQ: RVNC) is currently under investigation related to potential claims of securities fraud. This comes as a significant development for investors in the company who seek clarity and accountability in their financial dealings. Understanding the Investigation The...

Continue Reading
Salarius Pharmaceuticals Implements Strategic Stock Restructuring

Updated Category News Views 113

Salarius Pharmaceuticals' Strategic Move Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a leader in biopharmaceutical development dedicated to providing innovative cancer therapies, has announced an important decision regarding its stock structure. The clinical-stage company is set to execute a 1-for-15 reverse stock split, effective shortly. This significant action...

Continue Reading
Understanding Maine's Civic Health: Insights and Analysis

Updated Category News Views 84

The State of Civic Health in Maine Maine's civic health, despite the rising polarization in U.S. politics, stands resilient. A captivating new report by Colby College’s Goldfarb Center for Public Affairs uncovers insights into the civic engagement of its residents, calculated through various indicators. This comprehensive study, prepared alongside Public Engagement...

Continue Reading
Palantir Technologies (NASDAQ: PLTR) Surges to Record Highs

Updated Category News Views 136

Palantir Technologies Achieves New Stock Highs Palantir Technologies Inc. shares, noted under the ticker PLTR, have recently reached impressive all-time highs due to a combination of remarkable company performance and growing market interest. Record-Breaking Earnings Report The catalyst for this surge was the company’s latest earnings announcement, which showcased a...

Continue Reading